Positive top-line results for Pfizer’s Lyrica in Phase 3 Study of patients with Fibromyalgia in Japan
5 July 2011 | By Pfizer
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208...
List view / Grid view
News
Novartis drug Afinitor® met primary endpoint of Phase III study
5 July 2011 | By Novartis AG
Afinitor® in combination with exemestane extended progression-free survival in women with advanced breast cancer...
London 2012 partner, GlaxoSmithKline, shares scientific expertise with WADA to help fight against abuse of drugs in sport
4 July 2011 | By GlaxoSmithKline
GlaxoSmithKline signed a long-term agreement with the World Anti-Doping Agency...
Pfizer affirms CHANTIX/CHAMPIX as important treatment option for smokers wanting to quit
4 July 2011 | By Pfizer
An effective and appropriate treatment option for adult smokers wanting to quit...
Biogen Idec researchers identify novel approach for promoting Remyelination
3 July 2011 | By Biogen Idec
Results from a study that suggest that inhibiting death receptor-6 (DR6) function may represent a novel approach...
Lilly Quality Leader Walsh appointed to Company’s Executive Committee
1 July 2011 | By Eli Lilly and Company
Fionnuala Walsh, Ph.D., will join the executive committee of Eli Lilly and Company on July 1...
Lundbeck appoints Senior Vice President of HR
1 July 2011 | By H. Lundbeck A/S
H. Lundbeck A/S has appointed Teddy Hebo Larsen as Senior Vice President of HR...
Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)
1 July 2011 | By Novartis
Novartis announced that the US FDA approved once-daily Arcapta(TM) Neohaler(TM) (indacaterol inhalation powder)...
Merck statement on voluntary submission of clinical research protocols
1 July 2011 | By Merck
For its investigational and approved products...
GlaxoSmithKline receives new approval for Rotarix and significant new indication for Lamictal® (lamotrigine) in Japan
1 July 2011 | By GlaxoSmithKline
GSK announced that its rotavirus vaccine has received approval in Japan...
AstraZeneca’s NEXIUM receives first regulatory approval in Japan for the treatment of acid-related diseases
1 July 2011 | By AstraZeneca
NEXIUM 10 mg and 20 mg capsules have received regulatory approval in Japan...
Merck receives approval to market GARDASIL®, ZOLINZA® and CUBICIN®
1 July 2011 | By Merck
Merck announced that the Japanese MHLW approved three products – GARDASIL®, ZOLINZA® and CUBICIN®...
Novartis receives approval in Japan for Onbrez® Inhalation Capsules
1 July 2011 | By Novartis
Novartis has received regulatory approval in Japan for Onbrez® Inhalation Capsules (indacaterol)...
Thermo Fisher Scientific recognised as winner of the 2011 Microsoft Life Sciences Innovation Awards
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it is a 2011 winner of Microsoft Corporation’s Life Sciences Innovation Awards. This is the fourth consecutive year that the company has been recognized by Microsoft, demonstrating Thermo Fisher’s leading position as a provider of innovative enterprise…
Novartis Phase III study shows once-daily NVA237 is superior to placebo
30 June 2011 | By Novartis
Results from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237, 50 mcg significantly improved lung function...
